Select a page

Contact Us

Select a page

Home
About MBELR
- Current Team
- Past Boards
  - Volume 8
  - Volume 7
  - Volume 6
  - Volume 5
  - Volume 4
  - Volume 3
  - Volume 2
  - Volume 1
- Get Your Copy
- Submit Work
Print Edition
- Archive
Online Edition
Events
Sponsors

Home
About MBELR
- Current Team
- Past Boards
  - Volume 8
  - Volume 7
  - Volume 6
  - Volume 5
  - Volume 4
  - Volume 3
  - Volume 2
  - Volume 1
- Get Your Copy
- Submit Work
Print Edition
- Archive
Online Edition
Events
Sponsors

Posts tagged with ‘price’

Michigan Business & Entrepreneurial Law Review > price

Pharmaceutical Pricing: The Free Market and Government Regulation on Drug Companies
Since Martin Shkreli announced that he would lower the price of Daraprim by an unnamed amount at some point...
Read more
December 1, 2015
0
Pharmaceutical Pricing: The Intersection of Big Business and Healthcare
Until recently, Daraprim was a little known name.1 That is, until Turing Pharmaceuticals acquired the drug in August and...
Read more
October 13, 2015
0

Recent Posts

Two Years in Review: Are the Commonsense Principles of Corporate Governance 2.0 a Reagent for Success or Just Feel-Good Platitudes?
Guide to Transferring Title of Property
How COVID-19 May Affect Income Tax Deductions for Working from Home
The Patchwork Legal Landscape on Enforcing Mandatory Arbitration Agreements on Gig-Economy Workers – Activities vs. Passengers and Goods in Interstate Commerce
TRIPS and an Equitable Fight Against COVID-19

Archives

© 2021 Michigan Business & Entrepreneurial Law Review
University of Michigan Law School
625 South State Street, Ann Arbor, MI 48109